Behavioural Health Business Development Clinical Trials Pharma Companies 
pharmaphorum
APRIL 25, 2022
Aaron Gani, founder and CEO of BehaVR, and Krys Zaluski, director of business development, digital health at Sumitomo Dainippon Pharma, discuss their groundbreaking partnership to develop and commercialise digital therapeutics (DTx) products. . Configuring a collaboration. Everything’s moving so quickly.
pharmaphorum
JANUARY 26, 2021
There is an opportunity to address this at scale with digital tools and techniques, and expand support into just about any therapeutic area through the holistic integration of mental and behavioural health solutions that improve patient care. Clinical trials get more and more digitalised.
Expert insights. Personalized for you.
105 
Let's personalize your content